KEYWORDS
Introduction
Regulatory T cells (Tregs) are a subpopulation of CD4 þ cells and primarily maintain the immune system homeostasis of the organism. These cells have a high immunosuppressive potential for both innate and adaptive immunities. Disturbance of the cellular homeostasis results in either selfreactive autoimmune aggression or immune deficiency. The investigation of T cells with suppressive activity began in 1970, when new subpopulation of T-lymphocytes with immunosuppressive properties was first described. 1 Since this initial observation, numerous articles characterizing T cells with immune regulatory properties have been published; however, the mechanisms inherent to the immune response in these cells have not been fully elucidated.
Forkhead/winged-helix family box protein P3 and immunodysregulation, polyendocrinopathy, enteropathy, X-linked syndrome
The immune response that characterizes Tregs is realized through the action of the forkhead/winged-helix family box protein P3 (FOXP-3) (Scurfin). The functional activity of CD4 þ CD25 þ Tregs depends on the high expression of FOXP-3 gene and protein. FOXP-3 is a homodimer consisting of a proline-rich domain at the N-terminus in addition to a C2H2 zinc finger and a leucine zipper located in the center of the amino acid sequence. This central domain participates primarily in proteineprotein interactions, whereas the C-terminal end of FOXP-3 is a forkhead DNA-binding domain. FOXP-3 has regions that allow it to bind to approximately 700 genes and intergenically encoded microRNAs. In addition, FOXP-3 may have opposing effects on different genes, facilitating the transcription of some genes while repressing the transcription of others. Changes or defects in the coding sequence of the FOXP3 gene result in the development of different pathological conditions. Complete inactivation of FOXP3 gene because of a condition known as immunodysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. IPEX syndrome is very rare in humans and has only been observed in male patients. This syndrome is characterized by a number of complications, including diarrhea, a failure to thrive, eczema, atopic psoriasiform dermatitis, alopecia, hemolytic anemia, thrombocytopenia, neutropenia, hypo-or hyperthyroidism, lymphoadenopathy, Type 1 diabetes mellitus, and increased susceptibility to infections. Other clinical complications may include respiratory distress, bruising, hypocalcemia, hepatic parenchymal disease, cholestasis, hypertension, cardiomegaly, glomerulopathy, encephalopathy, and testicular atrophy. IPEX animal models show a phenotype characteristic of the scurfy mouse. 2 These animals have scaly skin, progressive anemia, thrombocytopenia, leucocytosis, lymphoadenopathy, various infections, diarrhea, gastrointestinal injury, cachexia, and hypogonadism in males, and they typically die within the first few weeks after birth. FOXP-3-related activation of Tregs has been demonstrated by the hypersensitivity of scurfy mice to activation through the T cell receptors. 3 Different changes of the regulation control by the FOXP-3 of FOXP-3-dependent genes result in alteration of Tregs functions and also because of further specific autoimmune disorders, such as systemic lupus erythematosus, rheumatoid arthritis, ulcerative colitis, Crohn's disease, celiac disease, hemolytic anemia, and asthma. 4 All genetic abnormalities that result in the onset of the IPEX syndrome and other selective syndromes as a consequence of mutations in genes dependent on FOXP-3 can be explained mainly by unspecific autoimmune aggression that is attributed to some aspects of the regulation of T cells and also the misbalance of regulation of FOXP-3-dependent genes, which is the result of separate manifestations of IPEX syndrome. In recent reports by Sugimoto 
Immune response regulation
The main function of FOXP-3 is to influence Tregs activity and, as a result, there is a possibility to regulate the activity of the immune reactions. The group of FOXP-3-dependent genes that are known to code separate proteins that may change the immune response was indicated. FOXP-3 may change expression of these genes because of suppression or activation of immune response members. The most wellknown genes from the aforementioned group include the cytotoxic T-lymphocyte-associated 4 (CTLA-4); inducible costimulator (ICOS); cyclic Adenosine Monophosphateresponsive element modulator (CREM); and PR [positive regulatory domain Iebinding factor 1 (PRDI-BNF1)-RIZ] domain containing 1, zinc finger (PRDM1) genes.
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Cytotoxic T-lymphocyte-associated 4
The CTLA-4 protein is coded by CTLA-4 gene, and it is similar to the lymphocyte CD28 molecule structure, with the exception that it is more competitive than CD28. CTLA-4 has a higher binding affinity to CD80 (B7.1) and CD86 (B7.2) in antigen-presenting cells. 8 Furthermore, inhibition of monocytes and macrophages by CTLA-4 is one of the primary mechanisms to repress the immune response by Tregs. 9 The up-expression of this receptor protein is also regulated by the FOXP-3 protein in natural and induced Tregs. 10 Interestingly, the application of the CTLA-4 antibody or specific deficiency of CTLA-4 caused the expected effects of severe yet reversible T cell-mediated autoimmune disease. 11 The low level of CTLA-4 expression was observed in patients with juvenile idiopathic arthritis. 12 Some human studies had shown that the administration of antibody to CTLA-4 resulted in tumor necrosis. 8 
Inducible costimulator
Another marker of FOXP-3 activity is ICOS. 13 The ICOS gene codes a protein ICOS, which participates in T cell receptor stimulation of T cells. In this case, CD28 is not required for the induction of ICOS. Data have indicated that there is an association between the expression of ICOS and the production of some cytokines. High expression of ICOS was correlated with the production of interleukin (IL)-10 in Tregs.
14 Two subpopulations of CD4 cyclic Adenosine Monophosphate-responsive element modulator CREM is upregulated in Tregs, located in natural and induced Tregs, and is dependent on FOXP-3 expression. 16 CREM protein activity is dependent on the concentration of intracellular calcium, which in turn regulates the activity of calcineurin and nuclear factor of activated T-cells (NFAT). Ca 2þ signaling leads to the activation of the members of the NFAT in the absence of AP-1. NFAT/activator protein (AP)-1 is a transcriptional complex, which upregulates the expression of genes involved in immune response. In the absence of AP-1, NFAT promotes T cell anergy program. Anergized T cells express increased levels of IL-10.
17 CREM modulates immune response, which was observed in the regulation of antimicrobial defense and immunity. 18 CREM also regulates cyclooxygenase-2, which suppresses effector FOXP3 T cells by a prostaglandin E 2 -dependent mechanism. 19 The role of CREM in the pathogenesis of diseases was observed in systemic lupus erythematosus and heart failure. 20 
PR (PRDI-BF1-RIZ) domain containing 1, zinc finger
PRDM1 is another protein-coding FOXP3-related gene that is expressed in Tregs. 21 PRDM1 was originally identified as PRDI-BF1, which functions as an inducible repressor of the transcription of the b-interferon gene expression. 22 This gene is essentially needed for terminal differentiation of B-lymphocytes to antibody-producing plasma cells. It highly expressed in effector and memory T cells of both CD4 and CD8 subpopulations. PR domain zinc finger protein 1 (Betainterferon gene positive regulatory domain I-binding factor) deficiency in T cells is because of enhanced proliferation and lethal multiorgan inflammatory disorders. 22 Blimp-1 may directly and indirectly repress interleukin 2 gene by means of FBJ murine osteosarcoma viral oncogene homolog, which is one of the components of AP-1 and is a strong activator of interleukin 2 gene. In the absence of Blimp-1, IL-2 levels might greatly increase, which causes autoaggressive response. 23 
Regulation of apoptosis and tumorigenesis
The other primary function of FOXP-3 is the regulation of genes coding apoptotic proteins. FOXP-3 expression induces apoptotic surface factors and suppresses intracellular and nucleic factors, including glucocorticoid-induced tumor necrosis factor receptor (TNFR)-related (GITR) protein, programmed cell death (PD)-1, and IL-7Ra. 5e7 The FOXP-3 protein may regulate genes that are involved in tumorigenesis. 24 Tumor cells release tumor growth factor beta in addition to some other factors that activate the proliferation of Tregs. Antibody-mediated FOXP-3 protein therapy induced apoptosis in cancer cells and inhibited metastasis, which was observed in breast, ovarian, and colon cancer cells. 25 FOXP-3 may be expressed by tumor cells. FOXP-3 also controls genes known to facilitate both the oncogenic transformation of cells and the processes of metastatic progression, such as neuropilin-1 (NRP-1), transforming growth factor beta receptor (TGFBR) 1, TGFBR2, and extracellular matrix protein 1 (ECM1).
Glucocorticoid-induced TNFR-related protein
GITR protein, a receptor belonging to the TNFR superfamily, is activated by GITR ligand (GITRL). GITRL belongs to the tumor necrosis factor family and is a Type II transmembrane protein. GITRL is expressed on antigenpresenting cells and B cells but not in T cells. GITR is expressed at low levels in resting responder T cells and is highly expressed in Tregs, and it is recognized as a marker of Tregs. 26 GITR protein stimulates T cellemediated antitumor immunity in mice. In humans, high expression of GITR in primary gastrointestinal cancers and tumor cell lines of different histological origin was observed. 27 
PD-1
The PD-1 belongs to CD28 family of receptors, expressed on T cells, B cells, and myeloid cells. These receptors are transmembrane proteins and are expressed as monomers. PD-1 binds to PD-L1 (B7-H1) and PD-L2 (B7-DC), which are homologs of B7-1 and B7-2 and are induced on antigenpresenting cells, and on various nonimmune cells. PD-1 negatively regulates cell activation and proliferation, causing cell cycle arrest without apoptosis. PD-1 recruits the protein tyrosine phosphatase, non-receptor type 11. PD-1 inhibits chronically activated cells and responses in peripheral, nonlymphoid tissues. PD-1 is expressed in Tregs, which promote the regulation of immune responses by these cells. 28 PD-1 may have intra-and extracellular localization. Activation of Tregs with high expression of FOXP-3 results in extracellular expression of PD-1. 29 Mice with knockout PD-1 gene develop autoimmune cardiomyopathy or a lupuslike syndrome. In humans, part of the immune deficiency associated with HIV infection may also be because of PD-1-mediated inhibition of T cell activation. 30 
Interleukin-7Ra
The IL-7Ra (CD127) is a Type I cytokine receptor chain devoid of intrinsic tyrosine kinase activity. It can bind IL-7 because of janus kinase 3-mediated phosphorylation of IL-7Ra and recruitment of janus kinase 2 and signal transducer and activator of transcription 5 transcription factors. IL-7 stimulates survival and expansion of immature precursors committed to the T and B cells. Patients with IL-7Ra deficiency present with signs and symptoms of severe combined immune deficiency, characterized by failure to thrive, recurrent otitis, viral infections, candidiasis, diarrhea, and fever. 31 Although most CD4 þ human T cells express IL-7Ra, Tregs exhibiting suppressive activity in vitro display distinctly lower surface expression of this marker. Expression of CD127 negatively correlates with FOXP-3 content, because FOXP-3 interacts with the CD127 promoter, contributing to the low expression of CD127 in CD4 þ CD25 þ Tregs. 32 Recent publications also propose that high expression of CD127 can modulate Tregs functions and decrease its suppressive activity. This fact was observed in patients with gastric cancer. 
CD25
þ Tregs. NRPs are membranous receptors capable of binding two disparate ligands, Class 3 semaphorins, and vascular growth factor, and regulating two diverse systems, neuronal guidance, and angiogenesis. NRP-1 is predominantly expressed on carcinomas. 34 The expression of NRP-1 by tumor cells is of great interest because NRP-1 and TGFb1 have been linked to cancer progression. NRP-1 is an important factor that binds to TGF-b1 in its activated and latency-associated peptide forms. NRP-1 is a receptor for TGF-b1 in Tregs, and it promotes Tregs activity. 35 In recent publications, it was proposed to use NRP-1 blockers for treatment of cancers.
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TGFBR1 and TGFBR2
Another FOXP3-related gene is TGFBR1. This gene codes protein TGF-bR1, which interacts with TGF-bR2 for further formation of complex with TGF-b1. Biochemically, TGF-bR1 and TGF-bR2 are serine/threonine kinases, which phosphorylate Smads. Furthermore to Smads, TGF-b1 also activates other signaling pathways, including various mitogenactivated protein kinases and phosphatidylinositol-3 kinase. TGF-b1 downregulates the proliferation and effector functions of T cells and the activation of macrophages. TGF-b and TGF-bR1 regulates differentiation or survival of Tregs. TGF-b signaling induces expression of the FOXP-3 and generation of Tregs from activated CD4 þ T cells. 37 TGF-b signaling is frequently perturbed in many human cancers, including renal cell carcinomas, colorectal cancer, nonsmall-cell lung cancer, and transitional cell carcinoma. 38 
Extracellular matrix protein 1
The ECM1 gene codes similarly named extracellular matrix protein. This is a secreted protein that has been implicated with extracellular matrix formation, cell adhesion, cell signaling, and regulation of tissue differentiation and maturation. Mutation of the ECM1 gene, leading to autosomal-recessive genodermatosis, lipoid proteinosis, also known as UrbacheWiethe disease, which is characterized by generalized thickening of the skin and mucosal infiltration with scarring. ECM-1 interacts with other extracellular matrix components, such as polysaccharides (hyaluronan, heparin, chondroitin sulfate A) and proteins [fibronectin, collagen IV, matrix metallopeptidase (MMP-9)], either as its reservoir or as its cofactor. The ECM-1 protein supports the processes of angiogenesis. It stimulates the proliferation of endothelial cells and promotes blood vessel formation, which may be the result of tumor progression and metastasis formation. Expression of ECM-1 closely correlates with the expression of FOXP-3 in CD4 þ
CD25
þ Tregs. 39 High expression of ECM-1 factor indicates the poor prognosis and metastatic progression of invasive breast ductal carcinoma, esophageal squamous carcinoma, gastric cancer, and colorectal cancer. 40 The primary function of FOXP-3-dependent genes is regulation of the immune responses by means of changes of CD4 þ
þ Tregs functionality, which may lead to disorders of the metabolism of various substances, disruptions in hormonal regulation, and misbalance in the cell cycle, and others. In this review, the main (immune response, apoptosis, and tumorigenesis regulation) functions of 10 FOXP-3-dependent genes are described, although many of FOXP-3-dependent genes and their functions remain unknown. Understanding the biological properties of FOXP-3 would have a wide range of implications for salvation of problems of immune escape in cancers, treatment of autoimmune disorders, regulation of inflammation, and immune response to infectious diseases. It is possible that the development of new strategies with genetic manipulations with the aim to change the expression of FOXP3 or FOXP-3-dependent genes may be helpful in the elaboration of new principles for treatment of many diseases and theirs complications.
